SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015800
Filing Date
2022-04-26
Accepted
2022-04-26 06:04:10
Documents
3
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20002876x1_def14a.htm DEF 14A 643278
2 ny20002876x1_pc1.jpg GRAPHIC 592447
3 ny20002876x1_pc2.jpg GRAPHIC 509205
  Complete submission text file 0001140361-22-015800.txt   2161000
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 22851634
SIC: 2834 Pharmaceutical Preparations